Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Evaluating the role of Burkholderia pseudomallei K96243 toxins BPSS0390, BPSS0395, and BPSS1584 in persistent infection.

Ross BN, Micheva-Viteva S, Hong-Geller E, Torres AG.

Cell Microbiol. 2019 Aug 10:e13096. doi: 10.1111/cmi.13096. [Epub ahead of print]

PMID:
31400259
2.

Single-cell correlations of mRNA and protein content in a human monocytic cell line after LPS stimulation.

Kalb DM, Adikari SH, Hong-Geller E, Werner JH.

PLoS One. 2019 Apr 19;14(4):e0215602. doi: 10.1371/journal.pone.0215602. eCollection 2019.

3.

Increased Mortality in Mice following Immunoprophylaxis Therapy with High Dosage of Nicotinamide in Burkholderia Persistent Infections.

Micheva-Viteva SN, Ross BN, Gao J, Adikari S, Zhang P, Mourant JR, Wu TH, Werner JH, Torres AG, Hong-Geller E.

Infect Immun. 2018 Dec 19;87(1). pii: e00592-18. doi: 10.1128/IAI.00592-18. Print 2019 Jan.

4.

PKC-η-MARCKS Signaling Promotes Intracellular Survival of Unopsonized Burkholderia thailandensis.

Micheva-Viteva SN, Shou Y, Ganguly K, Wu TH, Hong-Geller E.

Front Cell Infect Microbiol. 2017 Jun 7;7:231. doi: 10.3389/fcimb.2017.00231. eCollection 2017.

5.

Functional and Structural Analysis of a Highly-Expressed Yersinia pestis Small RNA following Infection of Cultured Macrophages.

Li N, Hennelly SP, Stubben CJ, Micheva-Viteva S, Hu B, Shou Y, Vuyisich M, Tung CS, Chain PS, Sanbonmatsu KY, Hong-Geller E.

PLoS One. 2016 Dec 28;11(12):e0168915. doi: 10.1371/journal.pone.0168915. eCollection 2016.

6.

Differential expression of small RNAs from Burkholderia thailandensis in response to varying environmental and stress conditions.

Stubben CJ, Micheva-Viteva SN, Shou Y, Buddenborg SK, Dunbar JM, Hong-Geller E.

BMC Genomics. 2014 May 19;15:385. doi: 10.1186/1471-2164-15-385.

7.

Actin restructuring during Salmonella typhimurium infection investigated by confocal and super-resolution microscopy.

Han JJ, Kunde YA, Hong-Geller E, Werner JH.

J Biomed Opt. 2014 Jan;19(1):16011. doi: 10.1117/1.JBO.19.1.016011.

8.

c-KIT signaling is targeted by pathogenic Yersinia to suppress the host immune response.

Micheva-Viteva SN, Shou Y, Nowak-Lovato KL, Rector KD, Hong-Geller E.

BMC Microbiol. 2013 Nov 9;13:249. doi: 10.1186/1471-2180-13-249.

9.

Small RNA-mediated regulation of host-pathogen interactions.

Harris JF, Micheva-Viteva S, Li N, Hong-Geller E.

Virulence. 2013 Nov 15;4(8):785-95. doi: 10.4161/viru.26119. Epub 2013 Aug 19. Review.

10.

Counting small RNA in pathogenic bacteria.

Shepherd DP, Li N, Micheva-Viteva SN, Munsky B, Hong-Geller E, Werner JH.

Anal Chem. 2013 May 21;85(10):4938-43. doi: 10.1021/ac303792p. Epub 2013 Apr 25.

PMID:
23577771
11.

Binding of nucleoid-associated protein fis to DNA is regulated by DNA breathing dynamics.

Nowak-Lovato K, Alexandrov LB, Banisadr A, Bauer AL, Bishop AR, Usheva A, Mu F, Hong-Geller E, Rasmussen KØ, Hlavacek WS, Alexandrov BS.

PLoS Comput Biol. 2013;9(1):e1002881. doi: 10.1371/journal.pcbi.1002881. Epub 2013 Jan 17.

12.

Identification of new ligands for the methionine biosynthesis transcriptional regulator (MetJ) by FAC-MS.

Martí-Arbona R, Teshima M, Anderson PS, Nowak-Lovato KL, Hong-Geller E, Unkefer CJ, Unkefer PJ.

J Mol Microbiol Biotechnol. 2012;22(4):205-14. doi: 10.1159/000339717. Epub 2012 Aug 8.

PMID:
22890386
13.
14.

DNA binding site analysis of Burkholderia thailandensis response regulators.

Nowak-Lovato KL, Hickmott AJ, Maity TS, Bulyk ML, Dunbar J, Hong-Geller E.

J Microbiol Methods. 2012 Jul;90(1):46-52. doi: 10.1016/j.mimet.2012.03.019. Epub 2012 Apr 13.

PMID:
22521922
15.

Discovery of DNA operators for TetR and MarR family transcription factors from Burkholderia xenovorans.

Maity TS, Close DW, Valdez YE, Nowak-Lovato K, Marti-Arbona R, Nguyen TT, Unkefer PJ, Hong-Geller E, Bradbury AR, Dunbar J.

Microbiology. 2012 Feb;158(Pt 2):571-82. doi: 10.1099/mic.0.055129-0. Epub 2011 Nov 24.

PMID:
22117006
16.

Functional gene discovery using RNA interference-based genomic screens to combat pathogen infection.

Hong-Geller E, Micheva-Viteva SN.

Curr Drug Discov Technol. 2010 Jun;7(2):86-94. Review.

PMID:
20836760
17.

Evaluation of Bacillus anthracis and Yersinia pestis sample collection from nonporous surfaces by quantitative real-time PCR.

Hong-Geller E, Valdez YE, Shou Y, Yoshida TM, Marrone BL, Dunbar JM.

Lett Appl Microbiol. 2010 Apr;50(4):431-7. doi: 10.1111/j.1472-765X.2010.02821.x. Epub 2010 Feb 8.

18.

A role for cell adhesion in beryllium-mediated lung disease.

Hong-Geller E.

J Occup Environ Hyg. 2009 Dec;6(12):727-31; quiz D102-3. doi: 10.1080/15459620903011160. Review.

PMID:
19894172
19.

Soluble MD2 increases TLR4 levels on the epithelial cell surface.

Lauer S, Kunde YA, Apodaca TA, Goldstein B, Hong-Geller E.

Cell Immunol. 2009;255(1-2):8-16. doi: 10.1016/j.cellimm.2008.08.009. Epub 2008 Oct 9.

PMID:
18845299
20.

The bioinorganic chemistry and associated immunology of chronic beryllium disease.

Scott BL, McCleskey TM, Chaudhary A, Hong-Geller E, Gnanakaran S.

Chem Commun (Camb). 2008 Jul 7;(25):2837-47. doi: 10.1039/b718746g. Epub 2008 May 9.

21.

Upregulation of I-CAM1 in response to beryllium exposure in small airway epithelial cells.

Rodriguez S, Kunde YA, McCleskey TM, Hong-Geller E.

Toxicol Lett. 2008 Jul 10;179(3):140-7. doi: 10.1016/j.toxlet.2008.04.014. Epub 2008 May 4.

PMID:
18539414
22.

Targeting toll-like receptor signaling pathways for design of novel immune therapeutics.

Hong-Geller E, Chaudhary A, Lauer S.

Curr Drug Discov Technol. 2008 Mar;5(1):29-38. Review.

PMID:
18537565
23.

Chemokine regulation in response to beryllium exposure in human peripheral blood mononuclear and dendritic cells.

Hong-Geller E, Pardington PE, Cary RB, Sauer NN, Gupta G.

Toxicology. 2006 Feb 1;218(2-3):216-28. Epub 2005 Nov 28.

PMID:
16314022
24.

Design of chimeric receptor mimics with different TcRVbeta isoforms. Type-specific inhibition of superantigen pathogenesis.

Hong-Geller E, Möllhoff M, Shiflett PR, Gupta G.

J Biol Chem. 2004 Feb 13;279(7):5676-84. Epub 2003 Nov 6.

25.

Therapeutic approaches to superantigen-based diseases: a review.

Hong-Geller E, Gupta G.

J Mol Recognit. 2003 Mar-Apr;16(2):91-101. Review.

PMID:
12720278
26.

Human neutrophils utilize a Rac/Cdc42-dependent MAPK pathway to direct intracellular granule mobilization toward ingested microbial pathogens.

Zhong B, Jiang K, Gilvary DL, Epling-Burnette PK, Ritchey C, Liu J, Jackson RJ, Hong-Geller E, Wei S.

Blood. 2003 Apr 15;101(8):3240-8. Epub 2003 Jan 2.

27.

Regulation of Akt-dependent cell survival by Syk and Rac.

Jiang K, Zhong B, Ritchey C, Gilvary DL, Hong-Geller E, Wei S, Djeu JY.

Blood. 2003 Jan 1;101(1):236-44. Epub 2002 Aug 29.

28.

Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.

Jiang K, Zhong B, Gilvary DL, Corliss BC, Vivier E, Hong-Geller E, Wei S, Djeu JY.

J Immunol. 2002 Apr 1;168(7):3155-64.

29.

Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells.

Jiang K, Zhong B, Gilvary DL, Corliss BC, Hong-Geller E, Wei S, Djeu JY.

Nat Immunol. 2000 Nov;1(5):419-25. Erratum in: Nat Immunol 2000 Dec;1(6):541.

PMID:
11062502
30.

Activated Cdc42/Rac reconstitutes Fcepsilon RI-mediated Ca2+ mobilization and degranulation in mutant RBL mast cells.

Hong-Geller E, Holowka D, Siraganian RP, Baird B, Cerione RA.

Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1154-9.

31.

Mutant RBL mast cells defective in Fc epsilon RI signaling and lipid raft biosynthesis are reconstituted by activated Rho-family GTPases.

Field KA, Apgar JR, Hong-Geller E, Siraganian RP, Baird B, Holowka D.

Mol Biol Cell. 2000 Oct;11(10):3661-73.

32.

Supplemental Content

Loading ...
Support Center